TOP NEWS

DermTech Raises $10M In Series C Funding

La Jolla-based molecular dermatology startup DermTech announced today that it has raised $10M in its Series C funding round, part of an ongoing $15M financing effort by the company. The startup, which is developing precision medicine technology for the diagnosis and treatment of skin cancers, inflammatory diseases, and other skin diseases, said the funding included investments by RTW Investments, along with other private investors. The company said the new funding will to expand its sales force and bring new skin cancer products to the market. More information »